MENU
ABOUT US
MAKE A DONATION
Login
SEARCH
CLOSE
Help Center
subscribe
newsletter
Newsstands
Epoch Shop
Gift
TOP NEWS
SPECIAL SERIES
SPECIAL COVERAGE
LATEST ARTICLES
US
US News
US Features
US Politics
US Crime News
New York
San Francisco
Los Angeles
Opinion
Thinking About China
Viewpoints
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
China News
US-China Relations
Chinese Regime
Business & Economy
Chinese Culture
China Human Rights
Social Issues
Organ Harvesting in China
World News
Africa News
Americas
Asia & Pacific
Canada
Europe
UK News
Australia News
International
Middle East
Business & Markets
Companies
Economy
Markets
Real Estate
Gold and Commodities
ARTS & CULTURE
Fine Arts & Craftsmanship
Performing Arts
Books
Traditional Culture
Shen Yun Special Coverage
Film & TV
Science
News
Space
Environment
Tech
Tech News
Tech Products & Reviews
Social Media
Sports
Videos
American Thought Leaders
China Insider
Crossroads
Bright
Lifestyle
Inspired
Family & Education
Personal Finance
American Essence
Entertainment
Film & TV
Entertainment News
Health
Experts
Conditions
Life & Wellness
Special Topics
Battlefields
Search Text
SEARCH
EpochTV
US
US Politics
Opinion
World News
China
Hong Kong
Health
Bright
Arts
Falun Gong
Premium
Markets
Games
Livestream
More
drugmaker
Drugmaker Amgen Lays Off 300 US Employees
Drugmaker Amgen Inc. said on Monday that it let go about 300 U.S. employees or about 1.2 percent of its total workforce, citing recent organizational changes to its commercial team. ...
January 30, 2023
BY
Reuters
Endo Files for Bankruptcy as US Opioid Litigation Drags
Endo International Plc. filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its ...
August 17, 2022
BY
Reuters
Japan’s Shionogi Seeks Approval for COVID-19 Pill
TOKYO—Drugmaker Shionogi & Co. Ltd. has applied for approval to make and sell its oral COVID-19 treatment in ...
February 26, 2022
BY
Reuters
Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
January 27, 2022
BY
Reuters
Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve ...
January 18, 2022
BY
Reuters
Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
Shares of Biogen Inc fell nearly 10 percent on Wednesday after the U.S. government announced limited coverage of ...
January 13, 2022
BY
Reuters
Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
December 30, 2021
BY
Reuters
AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
AstraZeneca will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker ...
September 29, 2021
BY
Reuters
EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
July 28, 2021
BY
Reuters
Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
ZURICH—Roche is looking for another location to carry out trials of its pill to fight COVID-19, after plummeting ...
April 21, 2021
BY
Reuters
EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
BRUSSELS—Europe's fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such ...
January 28, 2021
BY
Reuters
Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
NORMAN, Okla.—An Oklahoma judge on Aug. 26 found that Johnson & Johnson and its subsidiaries helped fuel the ...
August 26, 2019
BY
The Associated Press
Allergan’s Bold Patent Move Could Transform Pharma Landscape
Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug ...
November 11, 2017
BY
Fan Yu
Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
Eli Lilly has dropped a lower-than-expected 2016 forecast on Wall Street after wrapping up a year in which ...
January 5, 2016
BY
The Associated Press
TOP NEWS
FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
NEW
By
Kimberly Hayek
Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
2hr
By
Travis Gillmore
124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
2hr
By
Arthur Zhang
Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
2hr
By
Epoch Video
The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
3hr
By
Sheramy Tsai
Senate Panel Advances Bill to Make Hospitals Compete on Price
3hr
By
Lawrence Wilson
House Adopts Budget Blueprint for $95 Billion Reconciliation Package
4hr
By
Jackson Richman
House Passes Congressional Stock Trading Ban
4hr
By
Jackson Richman
and
Nathan Worcester
US Signs Nuclear Cooperation Deal With Saudi Arabia
4hr
By
Emel Akan
Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
5hr
By
Jack Phillips